Head and Neck Cancers
46
13
14
17
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
15.2%
7 terminated out of 46 trials
70.8%
-15.7% vs benchmark
0%
0 trials in Phase 3/4
18%
3 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (46)
A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality
Investigating the Diagnostic Performance of High-resolution Specimen PET-CT in Determining Margin Status in Cancer Resection
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer
Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma
Feasibility Study of CBCT for IGRT in Cancer Patients
IDOV-Immune for Advanced Solid Tumors
Food-related Quality of Life in Patients With Cancer
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Mental Health App for Cancer Survivors Study
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Biomedical Innovation for Facial Bone Reconstruction in Oncology: BIOFACE PASS a Medico-economic Study Describing the Standard Pathway of Patients Treated by Free Bone Flap
SOMESThesia and ALIMentation
Prospective Evaluation of Frailty in Patients With Head and Neck Tumors Before Curative Intended Therapy
Telemedicine Follow-Up for Early Laryngeal Cancer: a Randomized Controlled Trial Comparing Care Close to Home Versus Standard of Care
A Manualized Post-Traumatic Growth Intervention for People With Cancer in Greece - IC-Growth
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
Comparing Closed Face Masks vs Surface Guided Radiation Therapy for Head and Neck Radiotherapy
A Prospective, Multicenter, Multicohort Phase II Study: Evaluating the Efficacy and Safety of Preoperative Neoadjuvant Treatment With a PD-1 Inhibitor in Combination With Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma
Innovative OSA Screening in Head and Neck Cancer Patients With the Apneal App